Navigation Links
Clinical Experts Detail How They Use Varian's TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments
Date:9/14/2010

BARCELONA, Spain, Sept. 14 /PRNewswire/ -- Cancer treatment experts today reported their experiences with early treatments using the new TrueBeam system from Varian Medical Systems (NYSE: VAR), aimed at increasing the speed and precision of radiotherapy and radiosurgery treatments. Clinicians from the first two European hospitals to start clinical treatments using the new TrueBeam system – Zurich University Hospital in Switzerland and VU University Medical Center in Amsterdam, Netherlands - addressed an Emerging Technologies Symposium at the annual ESTRO conference here in Barcelona to give detailed accounts of early patient treatments.  

Professor Urs Luetolf of Zurich University Hospital said, "When we introduce new technology it is always interesting for our fellow radiation oncologists and radiation therapists to hear about clinical process improvements for treatment delivery and imaging which enables us to handle organ and tumor motion, but clinical medicine has one main goal – to add something for patient.

"We have treated more than 100 patients on the TrueBeam system since we introduced it six months ago and, although it's too early to assess outcomes, it's clear the system offers advantages in terms of the speed and precision of delivery," Prof. Luetolf added. "Cancer patients constantly seek a better cure and fewer side effects and they want to be treated using the latest and most advanced technology, and our experiences with this advanced system to date have been encouraging for patients as well as making the treatment process more straightforward for clinicians."

Professor Ben Slotman, head of radiation oncology at VU University Medical Center, outlined the results of patient treatments that commenced using the new TrueBeam system earlier this month, beginning with that of an 80-year-old lung cancer patient for whom surgery was deemed inappropriate because of her age and an earlier operation. She received eight stereotactic body radiosurgery treatments over a two-week period using TrueBeam in combination with RapidArc® technology and Professor Slotman described this pioneering treatment.

Professor Slotman also outlined key findings from two years of RapidArc radiotherapy treatments for more than 1,000 patients at VU, almost of third of them receiving hypo-fractionated, stereotactic body radiotherapy. "Delivering treatments rapidly is especially important when you need to deliver high doses with great precision, as shortening treatment times considerably reduces the extent of patient motion during treatment," he said.  

During a presentation on "Emerging Clinical Applications in Radiosurgery", Dr. John Adler, Varian's chief of new clinical applications, spoke about the use of hypo-fractionation for a range of cancers as well as other lesions, tumors and conditions where radiosurgery may be indicated.

TrueBeam

Designed to advance the treatment of lung, breast, prostate, head and neck, and other types of cancer, Varian's TrueBeam platform for image-guided radiotherapy and radiosurgery as introduced in April as the first fully-integrated system designed from the ground up to treat a moving target with unprecedented speed and accuracy.

Applicable for all forms of advanced external-beam radiotherapy including image-guided radiotherapy and radiosurgery (IGRT and IGRS), intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT) and RapidArc® radiotherapy, TrueBeam can deliver treatments with a dose delivery rate of up to 2400 monitor units per minute, double the maximum output of conventional systems. This makes it possible to offer greater patient comfort by shortening treatments, and to improve precision by leaving less time for tumor motion during dose delivery.  

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,200 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Oramed Pharmaceuticals Announces Successful Results of a Novel Exploratory Clinical Study of its Flagship Oral Insulin Capsule
2. First Patient Enrolled in CONNECT Clinical Trial
3. Reportlinker Adds Clinical Trials in China
4. Purdue Pharma L.P. to Present Data From Clinical Program for Butrans™ (buprenorphine) Transdermal System CIII at PAINWeek® 2010
5. Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients
6. MAP Pharmaceuticals Announces All Non-Asthmatic Patients Complete Treatment in Open-Label Trial and Completion of Treatment in QT Trial for LEVADEX™ Clinical Program
7. First AXL1717 Clinical Data From Ongoing Phase I/II Study in Cancer Patients has Been Published
8. Webmedx Strengthens Quality Program and Improves Patient Safety in Compliance with New Industry Standards for Clinical Documentation
9. Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
10. Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials
11. Morehead Memorial Hospital Goes Live with Thomson Reuters Clinical Xpert CareFocus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... -- LG Innotek hat heute die weltweit erste 70 mw ... 1,5-fache des 45-mW-Moduls der Konkurrenz. UV-C LED ... 280 nm und eignet sich damit für Sterilisationsaufgaben. Es verhindert ... Das Produkt von LG Innotek erzeugt UV-Strahlung im Bereich ... ...
(Date:2/23/2017)... China , 23. Februar 2017 Im ... , eine nationale Wirtschaftszone in der südwestlichen chinesischen Provinz Guizhou, ... der Errichtung einer Innovationsplattform aktiv an der Entwicklung einer eingebetteten ... Continue Reading ... ...
(Date:2/23/2017)... COTTAGE, New York , February 23, 2017 /PRNewswire/ ... health implications arising from increasing caseload for varicose veins ... recorded across the globe are prompting the adoption of ... latest study on global endovenous laser therapy ... attention towards aftereffects of lifestyle choices and consequences of ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... (PRWEB) February 23, ... the nation to come together to combine its favorite springtime ... its favorite fruit – apples! To celebrate National Nutrition Month, ... the “Apple Madness” bracket tournament – a five-week, five-round online ...
(Date:2/23/2017)... MN (PRWEB) , ... February 23, 2017 , ... HealthPostures, ... is sending an expert sit stand solutions representative to the Minneapolis Home and Garden ... Location for the event that is garnering national attention is the Minneapolis Convention Center. ...
(Date:2/22/2017)... ... 22, 2017 , ... Our high-octane society demands higher stands ... brain. , Power On, a mental performance enhancer from Modus Nutrition, provides scientifically ... capsule contains Cognizin® Citicoline, a branded form of the brain health nutrient citicoline ...
(Date:2/22/2017)... ... February 22, 2017 , ... Secure Exchange ... the largest network of hospitals, health information exchanges, physicians and patients, announced today ... Technology (ONC-HIT) 2015 Edition Health IT Module Certification via Drummond Group LLC, an ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... advanced data analytics to accurately understand each Medicare Advantage member’s risk, identify ... given population. This new solution helps transform the HCC Risk Adjustment process ...
Breaking Medicine News(10 mins):